Still operation though - due to having grown the exceed SBIR size standards - not program involved since 1998, Taconic provides high quality, precisely defined laboratory rats, mice and services for biomedical research. Taconic has a Quality Assurance Program that encompasses health monitoring, genetic integrity, environmental control and nutrition. In November, 2007, Taconic Farms, Inc. took a major stake in Artemis Pharmaceuticals GmbH from Artemis' parent company Exelixis, Inc., of South San Francisco (Nasdaq:EXEL). Artemis Pharmaceuticals GmbH changed its name to TaconicArtemis GmbH. In 2019, the firm had been acquired by HIG Capital. In November 2022 it was reported that Avista Capital Partners had acquired Taconic Biosciences for an undisclosed amount
